115 related articles for article (PubMed ID: 32108734)
1. Cervical cancer survivors' attitudes and understanding of menopause and hormone therapy.
Cotangco K; Class QA; Johnson TP; Kothari R
Menopause; 2020 Jun; 27(6):701-705. PubMed ID: 32108734
[TBL] [Abstract][Full Text] [Related]
2. Duration not severity of the climacteric syndrome predicts resumption of hormone therapy after discontinuation: a prospective cohort study.
Haimov-Kochman R; Barak-Glantz E; Ein-Mor E; Arbel R; Brzezinski A; Milwidsky A; Hochner-Celnikier D
Hum Reprod; 2006 Sep; 21(9):2450-4. PubMed ID: 16731546
[TBL] [Abstract][Full Text] [Related]
3. Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries.
Constantine GD; Graham S; Clerinx C; Bernick BA; Krassan M; Mirkin S; Currie H
Post Reprod Health; 2016 Sep; 22(3):112-22. PubMed ID: 26895640
[TBL] [Abstract][Full Text] [Related]
4. Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history.
Marino JL; Saunders CM; Emery LI; Green H; Doherty DA; Hickey M
Menopause; 2014 Mar; 21(3):267-74. PubMed ID: 23860358
[TBL] [Abstract][Full Text] [Related]
5. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
[TBL] [Abstract][Full Text] [Related]
6. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone therapy (HT) in patients with breast cancer.
Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
[TBL] [Abstract][Full Text] [Related]
8. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
Fournier A; Fritel X; Panjo H; Zins M; Ringa V
Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
[TBL] [Abstract][Full Text] [Related]
9. Acupuncture or phy(F)itoestrogens
Palma F; Fontanesi F; Facchinetti F; Cagnacci A
Gynecol Endocrinol; 2019 Nov; 35(11):995-998. PubMed ID: 31142156
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hormone therapy, factors associated with its use, and knowledge about menopause: a population-based household survey.
Pacello P; Baccaro LF; Pedro AO; Costa-Paiva L
Menopause; 2018 Jun; 25(6):683-690. PubMed ID: 29381660
[TBL] [Abstract][Full Text] [Related]
11. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years.
Lam PM; Leung TN; Haines C; Chung TK
Maturitas; 2003 Jun; 45(2):99-107. PubMed ID: 12787968
[TBL] [Abstract][Full Text] [Related]
12. Management of the menopause in cancer survivors.
Clemons M; Clamp A; Anderson B
Cancer Treat Rev; 2002 Dec; 28(6):321-33. PubMed ID: 12470982
[TBL] [Abstract][Full Text] [Related]
13. Symptoms, health behavior and understanding of menopause therapy in women with premature menopause.
Gibson-Helm M; Teede H; Vincent A
Climacteric; 2014 Dec; 17(6):666-73. PubMed ID: 24742007
[TBL] [Abstract][Full Text] [Related]
14. Finished herbal product as an alternative treatment for menopausal symptoms in climacteric women.
Lai JN; Hwang JS; Chen HJ; Wang JD
J Altern Complement Med; 2005 Dec; 11(6):1075-84. PubMed ID: 16398600
[TBL] [Abstract][Full Text] [Related]
15. Type of menopause, patterns of hormone therapy use, and hot flashes.
Gallicchio L; Whiteman MK; Tomic D; Miller KP; Langenberg P; Flaws JA
Fertil Steril; 2006 May; 85(5):1432-40. PubMed ID: 16566933
[TBL] [Abstract][Full Text] [Related]
16. Menopause after breast cancer: a survey on breast cancer survivors.
Biglia N; Cozzarella M; Cacciari F; Ponzone R; Roagna R; Maggiorotto F; Sismondi P
Maturitas; 2003 May; 45(1):29-38. PubMed ID: 12753941
[TBL] [Abstract][Full Text] [Related]
17. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.
Gupta P; Sturdee DW; Palin SL; Majumder K; Fear R; Marshall T; Paterson I
Climacteric; 2006 Feb; 9(1):49-58. PubMed ID: 16428125
[TBL] [Abstract][Full Text] [Related]
18. Changes in Australian women's perception of the menopause and menopausal symptoms before and after the climacteric.
Abraham S; Llewellyn-Jones D; Perz J
Maturitas; 1994 Dec; 20(2-3):121-8. PubMed ID: 7715463
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial factors, attitude to menopause and symptoms in Swedish perimenopausal women.
Olofsson AS; Collins A
Climacteric; 2000 Mar; 3(1):33-42. PubMed ID: 11910608
[TBL] [Abstract][Full Text] [Related]
20. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
